PL1927353T3 - Środek leczniczy na dolegliwości rogówki - Google Patents

Środek leczniczy na dolegliwości rogówki

Info

Publication number
PL1927353T3
PL1927353T3 PL06782954T PL06782954T PL1927353T3 PL 1927353 T3 PL1927353 T3 PL 1927353T3 PL 06782954 T PL06782954 T PL 06782954T PL 06782954 T PL06782954 T PL 06782954T PL 1927353 T3 PL1927353 T3 PL 1927353T3
Authority
PL
Poland
Prior art keywords
remedy
corneal diseases
corneal
diseases
Prior art date
Application number
PL06782954T
Other languages
English (en)
Inventor
Takahito Kimura
Shigeto Fujishita
Hiroyoshi Kawada
Original Assignee
Teika Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teika Pharmaceutical Co Ltd filed Critical Teika Pharmaceutical Co Ltd
Publication of PL1927353T3 publication Critical patent/PL1927353T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL06782954T 2005-08-24 2006-08-24 Środek leczniczy na dolegliwości rogówki PL1927353T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005242852 2005-08-24
EP06782954A EP1927353B1 (en) 2005-08-24 2006-08-24 Remedy for corneal diseases
PCT/JP2006/316550 WO2007023877A1 (ja) 2005-08-24 2006-08-24 角膜疾患治療剤

Publications (1)

Publication Number Publication Date
PL1927353T3 true PL1927353T3 (pl) 2012-04-30

Family

ID=37771620

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06782954T PL1927353T3 (pl) 2005-08-24 2006-08-24 Środek leczniczy na dolegliwości rogówki

Country Status (10)

Country Link
US (2) US20090247600A1 (pl)
EP (1) EP1927353B1 (pl)
JP (1) JP4778515B2 (pl)
CY (1) CY1112428T1 (pl)
DK (1) DK1927353T3 (pl)
ES (1) ES2377342T3 (pl)
PL (1) PL1927353T3 (pl)
PT (1) PT1927353E (pl)
SI (1) SI1927353T1 (pl)
WO (1) WO2007023877A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4778262B2 (ja) * 2005-04-27 2011-09-21 テイカ製薬株式会社 角膜疾患治療剤
JP5997416B1 (ja) * 2015-03-23 2016-09-28 キッセイ薬品工業株式会社 シェーグレン症候群に伴うドライアイの治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
JP3453152B2 (ja) * 1992-04-06 2003-10-06 格 冨山 抗炎症点眼剤
WO1999040071A1 (en) * 1998-02-05 1999-08-12 Senju Pharmaceutical Co., Ltd. Urocanic acid derivatives
DE60130922T2 (de) * 2001-01-02 2008-02-07 Astellas Pharma Inc. Peptide mit inhibierender Aktivität zur Produktion von Stickstoffmonoxid
JP4778262B2 (ja) 2005-04-27 2011-09-21 テイカ製薬株式会社 角膜疾患治療剤

Also Published As

Publication number Publication date
EP1927353A1 (en) 2008-06-04
JPWO2007023877A1 (ja) 2009-02-26
US20090247600A1 (en) 2009-10-01
CY1112428T1 (el) 2015-12-09
WO2007023877A1 (ja) 2007-03-01
PT1927353E (pt) 2012-02-07
EP1927353A4 (en) 2010-03-31
US8318739B2 (en) 2012-11-27
SI1927353T1 (sl) 2012-03-30
EP1927353B1 (en) 2011-11-23
DK1927353T3 (da) 2011-12-19
ES2377342T3 (es) 2012-03-26
JP4778515B2 (ja) 2011-09-21
US20100267665A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
IL185250A0 (en) Microimplants for ocular administration
EP2010187A4 (en) CONNECTIONS FOR DISEASES AND FUNCTIONAL DISORDERS
PT3424932T (pt) Boronoftalidas para utilização terapêutica
PL2533050T6 (pl) Możliwości leczenia choroby Fabry'ego
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
AP2006003671A0 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
EP1754485A4 (en) MEANS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
IL185444A0 (en) Novel drugs for treating respiratory diseases
EP1806145A4 (en) MEDICINE FOR THE TREATMENT OF INFLAMMATORY DISEASES
EP1852106A4 (en) SOLID OPHTHALMIC MEDICINE FOR EXTERNAL USE
GB0523961D0 (en) The treatment of ophthalmic diseases
GB0403370D0 (en) Device for preventing retinal diseases
EP1768656A4 (en) TREATMENT OF OCULAR DISEASES
GB0507003D0 (en) Therapeutic
EP1859795A4 (en) THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
EP1871344A4 (en) INHIBITABLE MEDICINAL PRODUCT
PL1876175T3 (pl) Środek terapeutyczny do leczenia chorób rogówki
EP1927353A4 (en) MEANS FOR THE TREATMENT OF CORNEAL DISEASES
EP2210878A4 (en) THERAPEUTIC AGENT AGAINST TRPV1-MEDIATED DISEASES
GB0523964D0 (en) The treatment of ophthalmic diseases
EP1958949A4 (en) THERAPEUTIC AGENT AGAINST HORNHAUT / BINDEHAUT DISEASE
GB0523962D0 (en) The treatment of ophthalmic diseases
GB0523965D0 (en) The treatment of ophthalmic diseases
AU2005901738A0 (en) Corneal shaping